BioLight Life Sciences Ltd. (TLV:BOLT)
Israel · Delayed Price · Currency is ILS · Price in ILA 342.30
+29.80 (9.54%)
Feb 20, 2026, 1:48 PM IDT
BioLight Life Sciences Market Cap
BioLight Life Sciences has a market cap or net worth of 30.97 million as of February 20, 2026. Its market cap has increased by 45.08% in one year.
Market Cap
30.97M
Enterprise Value
9.67M
Revenue
21.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
342.30
Market Cap Chart
Since January 11, 2006, BioLight Life Sciences's market cap has decreased from 47.74M to 30.97M, a decrease of -35.13%. That is a compound annual growth rate of -2.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 30.97M | -2.70% |
| Dec 31, 2025 | 31.83M | 25.69% |
| Dec 31, 2024 | 25.32M | 4.99% |
| Dec 31, 2023 | 24.12M | -19.99% |
| Dec 29, 2022 | 30.15M | -42.70% |
| Dec 30, 2021 | 52.62M | 53.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 589.80M |
| Geffen Residence & Renewal | 267.24M |
| Matricelf | 154.21M |
| Clal Biotechnology Industries | 47.05M |
| BioLineRx | 39.16M |
| XTL Biopharmaceuticals | 25.55M |
| Evogene | 23.91M |
| Purple Biotech | 18.58M |